We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Image-guided Adaptive Radiotherapy for Cervix Cancer: Patient Image Acquisition

This study has been terminated.
(Due to competing studies no further subjects could be recruited.)
Sponsor:
ClinicalTrials.gov Identifier:
NCT00571415
First Posted: December 12, 2007
Last Update Posted: June 1, 2016
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Collaborator:
National Cancer Institute (NCI)
Information provided by (Responsible Party):
Virginia Commonwealth University
  Purpose
Within this study patient data are collected from different imaging and motion monitoring devices that will be used to develop and test strategies for image-guided adaptive radiotherapy in cervix cancer patients.

Condition
Cervix Cancer

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Official Title: Image-guided Adaptive Radiotherapy for Cervix Cancer: Patient Image Acquisition

Further study details as provided by Virginia Commonwealth University:

Primary Outcome Measures:
  • Increase in therapeutic ratio [ Time Frame: 5 years ]

Enrollment: 21
Study Start Date: March 2009
Study Completion Date: October 2015
Primary Completion Date: May 2013 (Final data collection date for primary outcome measure)
Groups/Cohorts
cervix cancer patients

  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   Female
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population
University hospital clinic
Criteria

Inclusion Criteria:

  • Histological diagnosis of cervix cancer
  • Prescription of radiation treatment to the primary cancer

Exclusion Criteria:

  • Prior radiation treatment to the pelvis
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00571415


Locations
United States, Virginia
Viriginia Commonwealth University, Department of Radiation Oncology
Richmond, Virginia, United States, 23298
Sponsors and Collaborators
Virginia Commonwealth University
National Cancer Institute (NCI)
Investigators
Principal Investigator: Jeffrey F Williamson, PhD Virginia Commonwealth University, Department of Radiation Oncology
Study Director: Jeffrey F Williamson, PhD VCU, Richmond, VA
  More Information

Responsible Party: Virginia Commonwealth University
ClinicalTrials.gov Identifier: NCT00571415     History of Changes
Other Study ID Numbers: HM10390
P01CA116602 ( U.S. NIH Grant/Contract )
First Submitted: December 11, 2007
First Posted: December 12, 2007
Last Update Posted: June 1, 2016
Last Verified: May 2016

Keywords provided by Virginia Commonwealth University:
Image guided adaptive radiotherapy

Additional relevant MeSH terms:
Uterine Cervical Neoplasms
Uterine Neoplasms
Genital Neoplasms, Female
Urogenital Neoplasms
Neoplasms by Site
Neoplasms
Uterine Cervical Diseases
Uterine Diseases
Genital Diseases, Female